Help | RSS Feed



Ampio Pharmaceuticals, Inc. (NYSE:AMPE) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Ampio Pharmaceuticals, Inc. (NYSE:AMPE) seasonal charts above shows that a Buy Date of October 14 and a Sell Date of January 30 has resulted in a geometric average return of 13.12% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 31.09% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company focused primarily on developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process and decreasing vascular permeability. Ampio’s leading product candidates are Ampion and Optina. It is currently conducting the second pivotal clinical trial in the United States for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.

To download AMPE seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore